|
| Application in medicine |
| Geographic origin of propolis | Activity attributed | Test performed | References |
|
| Brazil (southern) | Anti-HIV activity | In vitro (H9 Lymphocytes) | [9] |
| Brazil | Anticancer activity | In vivo—mice (pulmonary tumors) | [85] |
| Brazil | Anticancer activity | In vitro (human tumor cell lines) | [86] |
| Brazil (group 3 and group 12) | Suppression of dioxin | In vitro | [87] |
| Chile | Antioxidant and anticancer | In vitro
(KB cells—human mouth epidermoid carcinoma cells;
Caco-2 cells—human colon adenocarcinoma cells) | [88] |
| Brazil | Anticancer activity | In vitro and in vivo (retinal damage) | [89] |
| Brazil (group 3, group 12, and bud resins of botanical origin) | Anticancer activity | In vitro (human prostate epithelial cells) | [90] |
| Brazil | Antiinfluenza virus activity | In vivo-mice (influenza virus) | [91] |
| Jordanian | Antibacterial | In vitro | [92] |
| Tunisia | Anticancer activity | In vitro (cancer cell lines—HT29, A549, Hep-2, raw264.7, and Vero) | [93] |
| Brazil (group 12 and artepellin C) | Immunosuppressant | In vitro (CD4 T cell) | [94] |
| Portugal | Anticancer activity | In vitro (human renal cancer) | [95] |
| Israel (Kibbutz Yad Mordecai and CAPE) | Anticancer activity | In vitro (human T-cell lines) | [96] |
| Brazil | Anticancer activity | In vitro (human breast cancer MCF-7 cells) | [97] |
| Brazil (group 12 and group 13) | Anticancer activity | In vitro (human cell lins of leukemia) | [98] |
| CAPE (derived from honeybee hive propolis) | Anticancer activity | In vitro (human prostate cancer cells) | [99] |
| Brazil | Anticancer activity | In vivo—mice (skin carcinogenesis) | [100] |
| Poland | Anticancer activity | In vitro (U87MG human glioblastoma) | [101] |
|
